![Drayton Wise](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Drayton Wise
Directeur/Bestuurslid bij
IRULYA THERAPEUTICS INC.
Profiel
Mr. Drayton Wise is on the Board of Directors at IRulya Therapeutics, Inc. Mr. Wise was previously employed as a Chief Commercial Officer by Insmed, Inc. He received his MBA from Emory University.
Actieve functies van Drayton Wise
| Bedrijven | Functie | Begin |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Directeur/Bestuurslid | 08-10-2026 |
Eerdere bekende functies van Drayton Wise
| Bedrijven | Functie | Einde |
|---|---|---|
| INSMED INCORPORATED | Corporate Officer/Principal | 16-04-2025 |
Opleiding van Drayton Wise
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
40
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
